Business Standard

Why are cheaper Covid-19 drugs not being promoted, asks Parliamentary panel

Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for Covid-19 treatment

Coronavirus, Covid

Healthcare workers collect swab samples from people residing at a slum area for COVID-19 testing in Mumbai on Saturday.

Press Trust of India New Delhi
A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and cap prices of expensive medicines pushed by pharma companies, sources said.
During a meeting of Parliamentary Standing Committee on Home Affairs, members also demanded that the maximum price of COVID-19 medicines be capped, they said.
Home Secretary Ajay Bhalla, Joint Secretary in Health Ministry Lav Agarwal and other officials were present in the meeting of the standing committee on home affairs chaired by Congress leader Anand Sharma.
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment, sources in the panel said.
The committee members expressed concern over black marketing of medicines.
Naming three cheaper and easily available medicines, the committee members questioned why are they not being promoted despite they being equally effective.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 15 2020 | 6:51 PM IST

Explore News